Choroidal Neovascularization
📧 Sign up to get email alerts when something new happens for Choroidal Neovascularization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. [Phase 3]
Phase 3 trial results and completion update for intravitreal ranibizumab in patients with vision loss due to choroidal neovascularization (C…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) [Phase 2]
This Phase 2 trial assessing bevacizumab in combination with Visudyne photodynamic therapy for age-related macular degeneration and related …
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen [Phase 2]
Phase 2 study evaluating an individualized regimen of ranibizumab for choroidal neovascularization caused by pathological myopia; study comp…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Intravitreal Bevacizumab in Agioid Streaks [Phase 1]
A Phase 1 study evaluating intravitreal bevacizumab for Angioid Streaks with choroidal neovascularization has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Sensitivity of the Home Macular Perimeter (HMP)
This completed clinical trial update assesses the sensitivity of the Home Macular Perimeter (HMP) in participants with age-related macular d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) [Phase 2]
Phase 2 dose-escalation study of PF-04523655, with and without ranibizumab, in diabetic macular edema, with exploration in related retinal d…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: 20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating intravitreal injections combining triamcinolone acetonide with ranibizumab (Lucentis) for neovascular …
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration
This clinical trial update reports the completion of a study evaluating the ForeseeHome home vision monitoring device after treatment of neo…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV) [Phase 3]
Phase 3 trial evaluating VEGF Trap-Eye for choroidal neovascularization due to pathologic myopia has completed, with results posted in 2014.…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial evaluating ranibizumab for choroidal neovascularization secondary to age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Evaluation of Dosing Interval of Higher Doses of Ranibizumab [Phase 4]
A Phase 4 clinical trial evaluated dosing intervals for higher doses of ranibizumab in age-related macular degeneration and choroidal neovas…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia [Phase 1]
Phase 1 trial evaluating reduced-fluence verteporfin photodynamic therapy in combination with ranibizumab for choroidal neovascularization i…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)
This completed trial compares Foresee Home with Optical Coherence Tomography (OCT) in detecting visual field defects in patients with choroi…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 trial evaluating an ocular sirolimus (rapamycin) formulation for age-related macular degeneration with choroidal neovascularizatio…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration [Phase 2]
Phase 2 study of ocular sirolimus in combination with Lucentis for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration [Phase 4]
Phase 4 clinical trial update evaluating reduced fluence photodynamic therapy with Visudyne in combination with Lucentis for age-related mac…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial [Phase 1]
Phase 1 clinical trial update for ranibizumab in hemorrhagic choroidal neovascularization, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial evaluating an adjunctive therapy to anti-VEGF for wet age-related macular degeneration. The study has completed and results we…
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial update evaluating a new adjunctive therapy to anti-VEGF for age-related macular degeneration; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Photodynamic and Pharmacologic Treatment of CNV [Phase 1, Phase 2]
This clinical trial update notes the completion of Phase 1 and Phase 2 studies investigating photodynamic and pharmacologic approaches to tr…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration [Phase 4]
Phase 4 clinical trial evaluating the safety and efficacy of ranibizumab in patients with choroidal neovascularization due to causes other t…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy [NA]
This completed clinical trial evaluated whether vitreous composition, as determined by ultrasound and OCT, influences ranibizumab therapy fo…
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) [Phase 2]
Phase 2 trial evaluating ranibizumab for choroidal neovascularization in patients with pseudoxanthoma elasticum has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 clinical trial evaluating intravitreal adalimumab for choroidal neovascularization secondary to age-related macular degeneration has…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO [NA]
An extension study assessing the safety and tolerability of Ranibizumab in subjects with choroidal neovascularization related to age-related…